IRX4204 / Io Therap  >>  Phase 2
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
IRX4204 / Io Therap
NCT00964132: Oral NRX 194204 Study in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)

Unknown status
2
48
US
NRX194204
NuRx Pharmaceuticals, Inc.
Non-small Cell Lung Cancer
03/10
06/10
NCT01540071: Trial of NRX 194204 in Castration- and Taxane-Resistant Prostate Cancer

Completed
2
38
US
NRX 194204, Rexinoid
Io Therapeutics
Castration Resistant Prostate Cancer
12/15
12/15

Download Options